MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Incremental hourly burden of “OFF” episodes on patient quality of life and health resource use among patients with Parkinson’s disease: A Neurologist/Patient Real World Assessment in the US

    K. Rajagopalan, J. Barton, J. Pike (Marlborough, MA, USA)

    Objective: To investigate the incremental hourly burden of “OFF” episodes on health resource utilization (HRU) and health- related- quality of life (HRQoL) from a real…
  • 2018 International Congress

    Neuromelanin-MRI in REM sleep behaviour disorder predicts dopaminergic dysfunction and clinical risk of Parkinson’s disease

    T. Barber, L. Griffanti, K. Bradley, D. McGowan, M. Crabbe, C. Lo, C. Mackay, J. Klein, M. Hu (Oxford, United Kingdom)

    Objective: To determine whether neuromelanin-MRI signal changes in the substantia nigra and locus coeruleus in patients with REM sleep behaviour disorder (RBD) are predictive of…
  • 2018 International Congress

    Effectiveness and safety of acupuncture in the treatment of Parkinson’s disease: A systematic review and meta-analysis of randomized controlled trials

    CN. Ko, SU. Park, SY. Cho, JM. Park (Seoul, Korea)

    Objective: This study aimed to examine the effectiveness and safety of acupuncture in the treatment of Parkinson’s disease (PD). Background: Background: Several previous studies have…
  • 2018 International Congress

    Real-World Outcomes Using a Novel Directional Lead from a Deep Brain Stimulation (DBS) Registry for Parkinson’s Disease

    G. Deuschl, R. Jain, H. Scholtes, A. Wang, M. Barbe, A. Kühn, M. Pötter-Nerger, J. Volkmann, S. Paschen, J. Vesper (Kiel, Germany)

    Objective: The objective of this report is to assess the initial real-world outcomes using a directional lead with a Deep Brain Stimulation (DBS) system capable…
  • 2018 International Congress

    Home based exercises to reduce falls in people with Parkinson’s disease: A randomized trial

    M. Morris, N. Taylor, J. McGinley, M. Danoudis, H. Menz (Bundoora, Australia)

    Objective: To measure the outcomes of a six week, twice weekly, home physiotherapy exercise and falls education program on falls, mobility and quality of life…
  • 2018 International Congress

    Evaluation clinical-biochemical features of Parkinson’s disease

    D. Daminov, G. Rakhmatullaeva (Tashkent, Uzbekistan)

    Objective: To study the features of the cytokine status under different forms and variants of PD course. Background: Parkinson’s disease is clinically heterogeneous; the etiology…
  • 2018 International Congress

    Safety of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson’s disease: Results from a Phase 3 double-blind, placebo-controlled trial

    R. Pahwa, R. Hauser, M. Worden, P. Bhargava, G. Vakili, A. Agro, D. Blum, W. Olanow, B. Navia (Kansas City, KS, USA)

    Objective: To evaluate the safety of APL-130277 (APL) in the double-blind, placebo-controlled trial Titration Phase (TP) and Maintenance Phase (MP). Background: OFF episodes are a…
  • 2018 International Congress

    Impact on the Quality of Life (CV) of people with Parkinson’s disease participating in community workshops of the public health system of Coquimbo, Chile

    S. Stange, D. Mansilla, Y. Diaz, Y. Córdoba (Coquimbo, Chile)

    Objective: To show the Impact in the CV of the People with Parkinson's Disease through the permanent assistance to the multidisciplinary community workshops of their…
  • 2018 International Congress

    The first case of Perry syndrome in Estonia

    K. Vender, T. Toomsoo, I. Kalju, I. Rubanovits, K. Joost, P. Taba (Tallinn, Estonia)

    Objective: Perry syndrome is an autosomal dominant disorder characterized by progressive parkinsonism and central hypoventilation. Background: Since the original publication in 1975 there have been…
  • 2018 International Congress

    Surgery-, hardware – and chronic stimulation-related adverse events following subthalamic nucleus deep brain stimulation for Parkinson’s disease

    B. Gonenli Kocer, E. Ozturk, S. Comoglu, M. Sorar, H. Kertmen (Ankara, Turkey)

    Objective: To evaluate the adverse events (AEs) following subthalamic nucleus (STN) deep brain stimulation (DBS) for Parkinson’s disease (PD) during 6 years period. Background: The…
  • « Previous Page
  • 1
  • …
  • 221
  • 222
  • 223
  • 224
  • 225
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley